dr. tolaney on recent advances in hr-positive breast cancer
Published 6 years ago • 210 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
1:20
dr tolaney on ongoing clinical trials in early-stage her2 breast cancer
-
2:06
dr. tolaney on deescalating therapy in stage i her2 breast cancer
-
1:00
dr. tolaney on remaining questions with cdk4/6 inhibitors in hr /her2- breast cancer
-
1:41
dr. tolaney on activity with abemaciclib in patients with hr /her2– breast cancer
-
1:39
dr. tolaney on sequencing strategies in metastatic her2 breast cancer
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer
-
1:53
dr. tolaney on navigating adjuvant therapy in early-stage her2 breast cancer
-
1:55
dr. tolaney on abemaciclib plus pembrolizumab for hr , her2- breast cancer
-
7:37
dr. tolaney highlights new breast cancer combination therapies
-
1:44
dr. tolaney on the atempt trial for her2 breast cancer
-
1:39
dr tolaney on standard frontline treatment approaches in her2 breast cancer
-
1:10
dr. tolaney discusses unmet needs in er breast cancer
-
1:24
dr. tolaney discusses pertuzumab in her2 breast cancer
-
1:38
dr. tolaney on cns recurrence in her2 breast cancer
-
1:32
dr. tolaney on the evolution of treatment in her2 breast cancer
-
1:08
dr. tolaney discusses the role of chemotherapy in her2 breast cancer
-
2:06
dr. tolaney on the apt and atempt trials in stage i her2 breast cancer
-
1:40
dr. tolaney discusses neratinib in her2 breast cancer